Ls. Sun et al., DEAMINOVASOPRESSIN HAS DIRECT AND MODULATORY EFFECTS ON VENTRICULAR AUTOMATICITY IN THE RAT-HEART, Cardiovascular Research, 27(9), 1993, pp. 1624-1628
Objective: Some neuropeptides have direct cardiac effects and also mod
ulate the cardiac effects of catecholamines. Vasopressin is an abundan
tly available neuropeptide having well known interactions with catecho
lamines in vascular smooth muscle. The aim of this study was to determ
ine the direct and modulatory effects of vasopressin on ventricular au
tomaticity. Methods: The cardiac effects of deaminovasopressin (dAVP),
a long acting synthetic analogue of vasopressin, were tested on basal
and alpha1 agonist induced changes in automaticity in isolated ventri
cular septal preparations from adult and neonatal rats after chronic e
xposure (10 mug.kg-1.d-1 subcutaneously for 10 d) and acute exposure (
in vitro bath superfusion with 10(-8) M dAVP for 1 h). Results: Chroni
c exposure to dAVP decreased basal ventricular automaticity in the adu
lt and in 10-11 d old rats. Although ot, agonists tended to decrease a
utomaticity in adult rat heart, prior chronic dAVP exposure altered th
e chronotropic response to alpha1 agonist so that only an increase in
automaticity was observed. A similar result was seen in adult ventricu
lar septal preparations upon acute superfusion with dAVP. Acute dAVP e
xposure reduced basal ventricular automaticity, and modified the alpha
1 adrenergic chronotropic response, such that only an increase in auto
maticity occurred. Acute dAVP exposure in adult ventricular septal pre
parations did not significantly change total alpha1 adrenergic recepto
r density or antagonist affinity, alpha1 adrenergic receptor subtype e
xpression, or the amount of pertussis toxin sensitive G protein measur
ed in an ADP ribosylation assay. Conclusions: dAVP not only exerted di
rect effects of chronotropy, but also influenced the expression of alp
ha1 adrenergic chronotropic responsiveness. If vasopressin has a simil
ar action, this may have important implications in instances where lev
els of this peptide are raised. For example, surgical stress and cardi
opulmonary bypass are clinical situations associated with increases in
both vasopressin and catecholamine levels. An interaction between the
two may contribute to the development of tachyarrhythmias in these se
ttings.